Skip to main content
. 2023 Sep 5;24(18):13715. doi: 10.3390/ijms241813715

Figure A2.

Figure A2

Differences in median treatment duration in patients with HCC treated with LEN between the LEN combined with TIT and LEN monotherapy groups.